19 Recruiting Studies Using Ustekinumab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Ustekinumab
A Long-term Extension Study of Ustekinumab in Pediatric Participants
📍 Children's Center For Digestive Healthcare, Llc — Atlanta, Georgia
Crohn Disease
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis
📍 Ps0021 50162 — Fountain Valley, California
Moderate to Severe Plaque Psoriasis
View Study & Checklist ➔Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2)
📍 Mount Sinai Hospital/UHN — Toronto, British Columbia
Type 1 Diabetes Mellitus
View Study & Checklist ➔Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)
📍 Advanced Gastroenterology, P.C /ID# 224396 — Chandler, Arizona
Crohn's Disease (CD)
View Study & Checklist ➔VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study
📍 GI Alliance - Sun City — Sun City, Arizona
Crohn's Disease
View Study & Checklist ➔A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
📍 Digestive Health Specialists of the Southeast — Dothan, Alabama
Crohn's Disease
View Study & Checklist ➔Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
📍 University of Massachusetts Chan Medical School — Worcester, Massachusetts
Skin Inflammation
View Study & Checklist ➔A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis
📍 Cahaba Research Inc — Birmingham, Alabama
Plaque Psoriasis
View Study & Checklist ➔Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant
📍 City of Hope Comprehensive Cancer Center, — Duarte, California
Hematologic and Lymphocytic Disorder
View Study & Checklist ➔Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
📍 University of California, San Francisco — San Francisco, California
Psoriasis
View Study & Checklist ➔Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
📍 University of California, San Diego — La Jolla, California
Psoriasis
View Study & Checklist ➔Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
📍 Local Institution - 0088 — Birmingham, Alabama
Plaque Psoriasis
View Study & Checklist ➔Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
Cancer
View Study & Checklist ➔Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
📍 University Hospitals Cleveland Medical Center — Cleveland, Ohio
Psoriasis
View Study & Checklist ➔An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Crohn's Disease
View Study & Checklist ➔A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
📍 BAMC — Houston, Texas
Crohn Disease
View Study & Checklist ➔Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
📍 NYU Langone Health — New York, New York
Rheumatic Disease
View Study & Checklist ➔De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis
📍 MUHC - Montreal General Hospital — Montreal, Quebec
Crohn Disease (CD)
View Study & Checklist ➔A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
📍 Digestive Health Specialsits — Dothan, Alabama
Crohn's Disease
View Study & Checklist ➔